Score Patients reaching composite outcome Patients not reaching composite outcome P value
(group A) (group B)
IFS Without 5 (33.3) 9 (60) 0.143
  With 10 (66.7) 6 (40)  
GFS Without 12 (80) 15 (100) 0.224
  With 3 (20) 0  
IL23 (Gn)n Without 6 (54.5) 9 (81.8) 0.361
  With 5 (45.5) 2 (18.2)  
IL23 (Gn)c Without 9 (81.8) 5 (45.5) 0.183
  With 2 (18.2) 6 (54.5)  
IL23 (Ga)n Without 12 (92.3) 6 (100) 1
  With 1 (7.7) 0  
IL23 (Ga)c Without 10 (76.9) 6 (100) 0.517
  With 3 (23.1) 0  
IL23 (ATn)n Without 15 (100) 15 (93.8) 1
  With 0 1 (6.3)  
IL23 (ATn)c Without 0 1 (6.3) 1
  With 15 (100) 15 (93.8)  
IL23 (ATa)c Without 0 1 (33.3) 0.3
  With 7 (100) 2 (66.7)  
IL23 (IT)c Without 14 (93.3) 11 (68.8) 0.172
  With 1 (6.7) 5 (31.3)  
IL23R (Gn)n Without 4 (44.4) 3 (30) 0.65
  With 5 (55.6) 7 (70)  
IL23R (Gn)c Without 8 (88.9) 8 (80) 1
  With 1 (11.1) 2 (20)  
IL23R (Ga)n Without 9 (69.2) 5 (71.4) 1
  With 4 (30.8) 2 (28.6)  
IL23R (Ga)c Without 13 (100) 5 (71.4) 0.111
  With 0 2 (28.6)  
IL23R (ATn)n Without 9 (60) 8 (50) 0.576
  With 6 (40) 8 (50)  
IL23R (ATn)c Without 2 (13.3) 3 (18.8) 1
  With 13 (86.7) 13 (81.3)  
IL23R (ATa)n Without 3 (50) 3 (75) 0.571
  With 3 (50) 1 (25)  
IL23R (ATa)c Without 1 (16.7) 1 (25) 1
  With 5 (83.3) 3 (75)  
IL23R (IT)n Without 10 (66.7) 13 (81.3) 0.433
  With 5 (33.3) 3 (18.8)  
IL23R (IT)c Without 10 (66.7) 9 (56.3) 0.552
  With 5 (33.3) 7 (43.8)  
Composite outcome: first event with doubling of SCr or declining eGFR more than 30%
IFS, interstitialfibrosis score; GFS, glomerular fibrosis score; (Gn)n, nuclear staining intensity of normal glomerulusmesangial cell; (Gn)c, cytoplasmic staining intensity of normal glomerulusmesangial cell; (Ga)n, nuclear staining intensity of atrophy glomerulusmesangial cell; (Ga)c, cytoplasmic staining intensity of atrophy glomerulusmesangial cell; (ATn)n, nuclear staining intensity of normal renal tubule; (ATn)c, cytoplasmic staining intensity of normal renal tubule; (ATa)n, nuclear staining intensity of atrophy renal tubule; (ATa)c, cytoplasmic staining intensity of atrophy renal tubule; (IT)n, nuclear staining intensity of interstitium; (IT)c, cytoplasmic staining intensity of interstitium.
p<0.05 indicates significance.
Table 2: Intensity of IL 23/IL-23 receptor expression in different regions of renal tissues divided by patient reach composite outcome (left) and patient did not reach composite outcome (right).